The aim of the course is to recall current trends and developments in European NPS markets, discuss current policies and identify barriers and problems in developing effective harm reduction responses targeting people who use drugs heavily in Europe.
With the aim of enhancing local service provision and seizing the opportunity for progress provided by a new generation of highly effective hepatitis C drugs, this roadshow will focus on showcasing good practice and identifying solutions for tackling hepatitis C.
The 4th edition of the extended Reitox network will focus on what we know about women using illicit drugs, what the gaps in knowledge are, and what the consequences could be for monitoring the situation and organising responses.
